Common genetic coagulation variants are not associated with ischemic stroke in a case-control study

Neurol Res. 2010 Jun;32(5):519-22. doi: 10.1179/016164109X12464612122533. Epub 2009 Aug 5.

Abstract

Objective: Abnormalities in the coagulation pathway are often included in the diagnostic work-up of stroke patients, especially in young adults with cryptogenic stroke.

Methods: Three common genetic variants within the coagulation cascade were investigated in 500 control subjects and in 167 patients with ischemic stroke defined by TOAST subclassification. Analysed variants were factor V Leiden, prothrombin 20210G-->A and factor XIII Val34Leu.

Results: The factor V Leiden mutation was over-represented in patients with cardioembolic stroke for trend, whereas the prothrombin 20210G-->A variant and the factor XIII polymorphism Val34Leu were not associated with stroke of any subtype. The three polymorphisms showed no association with stroke in subgroups of patients defined by age (<40, 40-49, 50-59, > or =60 years).

Discussion: This study suggests that the analysis of prothrombin 20210G-->A and factor XIII Val34Leu is not a useful diagnostic procedure in the work-up of ischemic stroke.

MeSH terms

  • Adult
  • Age Factors
  • Blood Coagulation / genetics
  • Blood Coagulation / physiology
  • Brain Ischemia / genetics*
  • Case-Control Studies
  • Factor V / genetics*
  • Factor V / metabolism
  • Factor XIII / genetics*
  • Factor XIII / metabolism
  • Female
  • Genetic Association Studies
  • Genetic Variation
  • Germany
  • Humans
  • Intracranial Embolism / genetics
  • Male
  • Middle Aged
  • Models, Cardiovascular
  • Polymorphism, Genetic*
  • Prothrombin / genetics*
  • Prothrombin / metabolism
  • Stroke / genetics*
  • White People / genetics

Substances

  • factor V Leiden
  • Factor V
  • Prothrombin
  • Factor XIII